Clinical Trials 370 Views Cantargia selects CAN10 as development project in systemic sclerosis and myocarditis Malin Otmani December 12, 2019 Cantargia has announced that its …
Intellectual Property 333 Views An opposition has been filed against one of Cantargia’s patents Malin Otmani October 16, 2019 An opposition has been filed …
Pharma Business 288 Views Cantargia submits request for pre-IND meeting Malin Otmani October 6, 2019 The company announced last month …
Clinical Trials 467 Views Positive preclinical data from Cantargia Malin Otmani August 26, 2019 The company has announced new …
Financing 366 Views Cantargia makes directed share issue of approximately SEK 106 million Malin Otmani March 22, 2019 The proceeds from the share …
Clinical Trials 1356 Views First patient treated in Cantargia’s CANFOUR trial Malin Otmani October 16, 2017 The first patient in the …
Intellectual Property 1125 Views US patent approval for Cantargia Malin Otmani October 9, 2017 Cantargia announces that the United …
Business article 1665 Views Business in focus: Cantargia Malin Otmani October 6, 2017 Swedish biotech company Cantargia recently …
Biotech Business 834 Views New patent approval for Cantargia Malin Otmani September 1, 2017 Cantargia announces that the European …
Clinical Trials 961 Views Cantargia gains approval to initiate clinical trial Malin Otmani August 3, 2017 Cantargia’s clinical trial application to …
Agreement 999 Views Cantargia enters collaboration agreement Malin Otmani June 16, 2017 Swedish Cantargia and Panorama Research …
Clinical Trials 1051 Views Cantargia initiates clinical trial Malin Otmani May 15, 2017 Cantargia has submitted the first …
Biotech Business 1094 Views Cantargia receives Intention to Grant Notice in Europe Malin Otmani April 10, 2017 Cantargia announces that the company …
Financing 879 Views Cantargia receives capital injection Malin Otmani January 24, 2014 Cantargia, a private biopharmaceutical company …
